PHARMACOKINETICS OF THE PROTON PUMP INHIBITOR PANTOPRAZOLE IN PATIENTS WITH SEVERE RENAL IMPAIRMENT

被引:0
|
作者
LINS, RL
DECLERCQ, I
HARTMANN, M
HUBER, R
BLIESATH, H
LUHMANN, R
WURST, W
机构
[1] AZ STUIVENBURG,RES UNIT,ANTWERP,BELGIUM
[2] BYK GULDEN LOMBERG GMBH,CONSTANCE,GERMANY
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A126 / A126
页数:1
相关论文
共 50 条
  • [11] Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor metrifonate in patients with renal impairment
    Dingemanse, J
    Halabi, A
    Kleinbloesem, CH
    Heinig, R
    Blume, H
    THERAPEUTIC DRUG MONITORING, 1999, 21 (03) : 310 - 316
  • [12] Effect of a proton pump inhibitor on the pharmacokinetics of imatinib
    Egorin, Merrill J.
    Shah, Dhvani D.
    Christner, Susan M.
    Yerk, Mara A.
    Komazec, Kristin A.
    Appleman, Leonard R.
    Redner, Robert L.
    Miller, Brian M.
    Beumer, Jan H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (03) : 370 - 374
  • [13] The clinical importance of proton pump inhibitor pharmacokinetics
    Yacyshyn, BR
    Thomson, ABR
    DIGESTION, 2002, 66 (02) : 67 - 78
  • [14] Pantoprazole, Prout and the proton pump
    Playford, RJ
    Podas, T
    Modlin, I
    HOSPITAL MEDICINE, 1999, 60 (07): : 500 - 504
  • [15] Preliminary results of the proton-pump inhibitor pantoprazole in patients with Zollinger-Ellison syndrome
    Radebold, K
    Bornman, PC
    vanWyk, MEC
    Kaye, P
    Marks, IN
    Terblanche, J
    GASTROENTEROLOGY, 1997, 112 (04) : A37 - A37
  • [16] PHARMACOKINETICS OF CEFODIZIME IN ELDERLY PATIENTS WITH MODERATE OR SEVERE RENAL IMPAIRMENT
    VEYSSIER, P
    DEVILLERS, A
    DOMART, Y
    FOURTILLAN, JB
    BRYSKIER, A
    PROCYK, T
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 : 77 - 81
  • [17] Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy
    Wöhrer, S
    Bartsch, R
    Hejna, M
    Drach, J
    Raderer, M
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2005, 40 (10) : 1222 - 1225
  • [18] THE EFFECT OF SEVERE RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF THE INVESTIGATIONAL HCV PROTEASE INHIBITOR TELAPREVIR
    van Heeswijk, R.
    Vandevoorde, A.
    Boogaerts, G.
    De Paepe, E.
    van Solingen-Ristea, R.
    Garg, V.
    Beumont, M.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S492 - S492
  • [19] Pantoprazole (Proton Pump Inhibitor) Contributing to Torsades de Pointes Storm
    Bibawy, John N.
    Parikh, Valay
    Wahba, Joseph
    Barsoum, Emad A.
    Lafferty, James
    Kowalski, Marcin
    Bekheit, Soad
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (02): : E17 - E19
  • [20] Allergic reaction to proton pump inhibitor: Pantoprazole induced Kounis syndrome
    Canpolat, Ugur
    Sahiner, Levent
    Aytemir, Kudret
    Oto, Ali
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 159 (02) : E27 - E28